Skip to main navigation
Skip to content
  • Contact
  • Twitter
  • Linkedin
gbt
  • About
    • Our Company
    • Leadership
    • Board of Directors
    • Contact Us
    • Careers
  • Our Commitment
    • Patients & Advocacy
    • GBT’s Supported Conferences
    • COVID-19 Information and Resources
    • Corporate Giving
    • The GBT Foundation
    • Expanded Access
    • Environmental, Social and Governance
  • Research
    • Sickle Cell Disease
    • Pipeline
    • Externally Sponsored Research (ESR)
    • Partnerships
    • Publications
  • Our Medicine
  • Investors & Media
    • Company Summary
    • Media Resources
    • Press Releases
    • Events & Presentations
    • Quarterly Results
    • Analyst Coverage
    • Stock Information
    • SEC Filings
    • Governance
    • Investor FAQs
  • Careers
    • Jobs
  • Contact Us
  • Twitter
  • LinkedIn
Investors & Media
  • Company Summary
  • Media Resources
  • Press Releases
  • Events & Presentations
  • Quarterly Results
  • Analyst Coverage
  • Stock Information
  • SEC Filings
  • Governance
  • Investor FAQs
  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contact

Proxy Statements

  • Annual Reports
  • Proxy Statements
  • Quarterly & Other Reports

Proxy Statements

Date Documents
Apr 28, 2022
2022 Proxy Statement
Apr 28, 2021
2021 Proxy Statement
Apr 28, 2020
2020 Proxy Statement
Apr 29, 2019
2019 Proxy Statement
Apr 26, 2018
2018 Proxy Statement
Apr 28, 2017
2017 Proxy Statement
Apr 28, 2016
2016 Proxy Statement
  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contact
gbt

Copyright 2022
Global Blood Therapeutics, Inc.

  • Privacy Policy
  • Online Tracking Opt-Out Guide
  • Terms of use
  • Community Guidelines

P-VOX-US-00501

  • About
    • Our Company
    • Leadership
    • Board of Directors
    • Contact Us
    • Careers
  • Our Commitment
    • Patients & Advocacy
    • GBT’s Supported Conferences
    • COVID-19 Information and Resources
    • Corporate Giving
    • The GBT Foundation
    • Expanded Access
    • Environmental, Social and Governance
  • Research
    • Sickle Cell Disease
    • Pipeline
    • Externally Sponsored Research (ESR)
    • Partnerships
    • Publications
  • Our Medicine
  • Investors & Media
    • Company Summary
    • Media Resources
    • Press Releases
    • Events & Presentations
    • Quarterly Results
    • Analyst Coverage
    • Stock Information
    • SEC Filings
    • Governance
    • Investor FAQs
  • Careers
    • Jobs
  • Contact Us
  • Twitter
  • LinkedIn
This site uses cookies to give you the best online experience. Learn more, including how to disable certain cookies on our Privacy Page. Accept
Privacy & Cookies Policy